PATENT CLAIM ANALYSIS

Application Number: 16009590
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-03
Patent Classification: ["514", "265100"]

Abstract:
There are disclosed certain 1-[2-(aminomethyl)benzyl]-2-thioxo-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyrimidin-4-one compounds of formula (I), and pharmaceutically acceptable salts thereof, together with compositions containing them and their use in therapy. The compounds are inhibitors of the enzyme MPO and are thereby particularly useful in the treatment or prophylaxis of cardiovascular disorders such as heart failure and coronary artery disease related conditions.

Claim (Index 18):
A method of identifying a patient suitable for MPO inhibitor treatment encompassing the measurement of plasma urate levels.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 94.0
- Lexical Diversity: 1.2807
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14951979', '15454318', '11720913', '15756373', '14487009']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7438757643000716
- 35 USC 102 Novelty (BERT): 0.5459989738470117
- Combined Prediction Score: 0.7240880852547656
- Mean Citation Score: 274.46071
- Max Citation Score: 384.9413
- Similarity Product: 215.7117697184384

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test